Oliver Luxxe Assets’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-16,949
Closed -$1.35M 199
2022
Q2
$1.35M Buy
16,949
+894
+6% +$71.3K 0.4% 81
2022
Q1
$1.69M Buy
16,055
+547
+4% +$57.5K 0.43% 87
2021
Q4
$1.67M Buy
15,508
+1,715
+12% +$185K 0.42% 92
2021
Q3
$1.51M Buy
+13,793
New +$1.51M 0.42% 88
2021
Q2
Sell
-19,331
Closed -$1.78M 208
2021
Q1
$1.78M Buy
19,331
+678
+4% +$62.4K 0.53% 72
2020
Q4
$1.47M Sell
18,653
-3,444
-16% -$271K 0.46% 82
2020
Q3
$1.72M Sell
22,097
-860
-4% -$66.8K 0.64% 56
2020
Q2
$1.28M Buy
+22,957
New +$1.28M 0.67% 52